Ocean Biomedical Stock Performance
| OCEAW Stock | 0.04 0 9.77% |
On a scale of 0 to 100, Ocean Biomedical holds a performance score of 4. The company holds a Beta of -1.37, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ocean Biomedical are expected to decrease by larger amounts. On the other hand, during market turmoil, Ocean Biomedical is expected to outperform it. Please check Ocean Biomedical's total risk alpha and the relationship between the potential upside and day typical price , to make a quick decision on whether Ocean Biomedical's historical price patterns will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ocean Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ocean Biomedical showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks | 11/22/2024 |
| Begin Period Cash Flow | 34 K |
Ocean |
Ocean Biomedical Relative Risk vs. Return Landscape
If you would invest 4.22 in Ocean Biomedical on September 1, 2024 and sell it today you would lose (0.62) from holding Ocean Biomedical or give up 14.69% of portfolio value over 90 days. Ocean Biomedical is currently producing 0.8008% returns and takes up 15.0453% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Ocean, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ocean Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ocean Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Ocean Biomedical, and traders can use it to determine the average amount a Ocean Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0532
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OCEAW | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.05 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.8 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Ocean Biomedical is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocean Biomedical by adding it to a well-diversified portfolio.
Ocean Biomedical Fundamentals Growth
Ocean Stock prices reflect investors' perceptions of the future prospects and financial health of Ocean Biomedical, and Ocean Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ocean Stock performance.
| EBITDA | (957.74 K) | ||||
| Net Income | (114.47 M) | ||||
| Total Debt | 12.12 M | ||||
| Cash Flow From Operations | (9.43 M) | ||||
| Total Asset | 5.5 M | ||||
| Retained Earnings | (196.06 M) | ||||
| Working Capital | (27.9 M) | ||||
About Ocean Biomedical Performance
Evaluating Ocean Biomedical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Ocean Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ocean Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.03) | (0.03) | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Ocean Biomedical performance evaluation
Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Ocean Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (114.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| Latest headline from news.google.com: Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks |
- Analyzing Ocean Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ocean Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Ocean Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ocean Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ocean Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ocean Biomedical's stock. These opinions can provide insight into Ocean Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Ocean Stock Analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.